SCHEMBL7514732

SCHEMBL7514732

NCCC1CCCN(Cc2ccccc2)C1

nearest known ligand 0.59

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.59
ALDH1A1 P00352 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C19 P33261 1/20 0.59
BCHE P06276 4/20 0.52
ACHE P22303 2/20 0.52
MAOB P27338 1/20 0.52
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
CCR3 P51677 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5969011 0.91 CCR3 (0.58) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL4621517 0.91 CCR3 (0.58) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL537415 0.91 CCR3 (0.58) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL5463699 0.90 ALDH1A1 (0.55) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL992110 0.88 CYP2D6 (0.62) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL11199596 0.86 CYP2D6 (0.60) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL21812109 0.86 CTSS (0.61) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL9598912 0.86 CTSS (0.61) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
Hydrochloric Acid SCHEMBL31687488 0.86 CYP2D6 (0.60) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL7337185 0.85 CYP2D6 (0.66) CYP2D6ALDH1A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255739-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-11-13 EP disclosed
WO-2001053273-A1 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 2001-07-26 WO disclosed